Yuan H - Search Results

1

Progression Risk Assessment of Post-surgical Papillary Thyroid Carcinoma Based on Circular RNA-Associated Competing Endogenous RNA Mechanisms.

Wu M, Li S, Han J, Liu R, Yuan H, Xu X, Li X, Liu Z. Wu M, et al. Among authors: yuan h. Front Cell Dev Biol. 2021 Jan 21;8:606327. doi: 10.3389/fcell.2020.606327. eCollection 2020. Front Cell Dev Biol. 2021. PMID: 33553144 Free PMC article.

2

Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2-mediated mitochondrial fission.

Li X, Wu M, An D, Yuan H, Li Z, Song Y, Liu Z. Li X, et al. Among authors: yuan h. J Cell Physiol. 2019 Sep;234(9):16238-16251. doi: 10.1002/jcp.28287. Epub 2019 Feb 11. J Cell Physiol. 2019. PMID: 30741413

3

Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.

Wu M, Yuan H, Li X, Liao Q, Liu Z. Wu M, et al. Among authors: yuan h. Front Endocrinol (Lausanne). 2019 Nov 15;10:790. doi: 10.3389/fendo.2019.00790. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31803141 Free PMC article.

4

Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.

Wu M, Li X, Liu R, Yuan H, Liu W, Liu Z. Wu M, et al. Among authors: yuan h. J Cancer. 2020 Aug 29;11(21):6299-6318. doi: 10.7150/jca.47629. eCollection 2020. J Cancer. 2020. PMID: 33033514 Free PMC article.

5

MicroRNA-7 regulates the proliferation and metastasis of human papillary carcinoma cells by targeting Bcl-2.

Li X, Liu R, Wang Z, Wu M, Chang L, Yuan H, Zhuang F, Song Y, Liu Z. Li X, et al. Among authors: yuan h. Am J Transl Res. 2020 Sep 15;12(9):5772-5780. eCollection 2020. Am J Transl Res. 2020. Retraction in: Am J Transl Res. 2021 Jul 15;13(7):8525. PMID: 33042456 Free PMC article. Retracted.

6

A novel prognostic model for papillary thyroid cancer based on epithelial-mesenchymal transition-related genes.

Liu R, Cao Z, Pan M, Wu M, Li X, Yuan H, Liu Z. Liu R, et al. Among authors: yuan h. Cancer Med. 2022 Dec;11(23):4703-4720. doi: 10.1002/cam4.4836. Epub 2022 May 24. Cancer Med. 2022. PMID: 35608185 Free PMC article.

7

A Novel Immune-Related ceRNA Network and Relative Potential Therapeutic Drug Prediction in ccRCC.

Li W, Meng X, Yuan H, Xiao W, Zhang X. Li W, et al. Among authors: yuan h. Front Genet. 2022 Jan 25;12:755706. doi: 10.3389/fgene.2021.755706. eCollection 2021. Front Genet. 2022. PMID: 35145542 Free PMC article.

8

Identification of candidate biomarker EMP3 and its prognostic potential in clear cell renal cell carcinoma.

Lv Q, Xiao W, Xiong Z, Shi J, Miao D, Meng X, Yuan H, Yang H, Zhang X. Lv Q, et al. Among authors: yuan h. Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1176-1190. doi: 10.52586/5018. Front Biosci (Landmark Ed). 2021. PMID: 34856762 Free article.

9

CircPTK2/PABPC1/SETDB1 axis promotes EMT-mediated tumor metastasis and gemcitabine resistance in bladder cancer.

Meng X, Xiao W, Sun J, Li W, Yuan H, Yu T, Zhang X, Dong W. Meng X, et al. Among authors: yuan h. Cancer Lett. 2023 Feb 1;554:216023. doi: 10.1016/j.canlet.2022.216023. Epub 2022 Nov 25. Cancer Lett. 2023. PMID: 36436682 Free article.

10

Hsa_circ_0086414/transducer of ERBB2 (TOB2) axis-driven lipid elimination and tumor suppression in clear cell renal cell cancer via perilipin 3.

Meng X, Li W, Yu T, Lu F, Wang C, Yuan H, Yang W, Dong W, Xiao W, Zhang X. Meng X, et al. Among authors: yuan h. Int J Biol Macromol. 2024 Mar;261(Pt 1):129636. doi: 10.1016/j.ijbiomac.2024.129636. Epub 2024 Jan 23. Int J Biol Macromol. 2024. PMID: 38272402

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,106 results

Search Page

Filters